Cochrane · systematic review · CD007787

Drugs for treating giardiasis

Granados, CE, Reveiz, L, Uribe, LG, et al. · Cochrane Database of Systematic Reviews · 2012 · Cochrane Library

Infectious DiseasesAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
14
current version
GRADE rated
11
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 3 · 21.4%Very low 7 · 50%Low 1 · 7.1%Moderate 3 · 21.4%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Comparison

Population: People with giardiasis infection
4 questions
OutcomeEffectEvidenceStatus / GRADE
Parasitological cure (
RR 0.99 [0.95, 1.03]10 studies · 932 participantsModerate
Downgraded: risk of bias
Clinical improvement (
RR 0.98 [0.93, 1.04]5 studies · 483 participantsModerate
Downgraded: risk of bias
Gastrointestinal side effects (
RR 0.29 [0.13, 0.63]8 studies · 717 participantsModerate
Downgraded: risk of bias
Neurological side effects (
RR 0.34 [0.18, 0.64]5 studies · 453 participantsLow
Downgraded: risk of bias, imprecision

Comparison

Population: People with giardiasis infection
5 questions
OutcomeEffectEvidenceStatus / GRADE
Parasitological cure (
RR 0.58 [0.32, 1.06]5 studies · 142 participantsVery low
Downgraded: risk of bias, imprecision
Clinical improvement
no estimate extracted0 studies · 0 participantsUngraded
Side effects: nausea/vomiting
RR 0.32 [0.05, 1.9]3 studies · 100 participantsVery low
Downgraded: risk of bias, imprecision
Side effects: headache
RR 0.24 [0.03, 2.06]2 studies · 74 participantsVery low
Downgraded: risk of bias, imprecision
Serious adverse events
no estimate extracted5 studies · 142 participantsUngraded

Comparison

Population: People with giardiasis infection
5 questions
OutcomeEffectEvidenceStatus / GRADE
Parasitological cure (
RR 1.23 [0.87, 1.73]3 studies · 179 participantsVery low
Downgraded: risk of bias, imprecision
Clinical improvement (
RR 1.15 [1, 1.32]3 studies · 179 participantsVery low
Downgraded: risk of bias, imprecision
Gastrointestinal side effects (
RR 0.58 [0.21, 1.62]3 studies · 179 participantsVery low
Downgraded: risk of bias, imprecision
Neurological side effects (
RR 1.3 [0.29, 5.92]2 studies · 138 participantsVery low
Downgraded: risk of bias, imprecision
Serious adverse events
no estimate extracted3 studies · 179 participantsUngraded